Covered recipient · General Payments record
SUSAN M ROBINS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,729.22
- Reported across 110 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $438.35 | 24 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $124.08 | 6 |
| ABBVIE INC. | $108.97 | 5 |
| Amgen Inc. | $50.32 | 3 |
| Exact Sciences Corporation | $47.12 | 3 |
| Lilly USA, LLC | $30.09 | 2 |
| PFIZER INC. | $20.84 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.34 | 1 |
| CVRx Inc. | $14.06 | 1 |
| Acerta Pharma LLC | $13.27 | 1 |
| Phathom Pharmaceuticals, Inc. | $13.26 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.84 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105959198 | CMS |
| ABBVIE INC. | $33.25 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105959200 | CMS |
| ABBVIE INC. | $22.00 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105959202 | CMS |
| ABBVIE INC. | $14.15 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105959204 | CMS |
| ABBVIE INC. | $15.73 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105959206 | CMS |
| Amgen Inc. | $15.89 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117667977 | CMS |
| Amgen Inc. | $18.93 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117667979 | CMS |
| Amgen Inc. | $15.50 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117667981 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.27 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105739270 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.34 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118053635 | CMS |
| CVRx, Inc. | $14.06 | 07/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138420360 | CMS |
| Exact Sciences Corporation | $16.63 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114857241 | CMS |
| Exact Sciences Corporation | $16.63 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114857247 | CMS |
| Exact Sciences Corporation | $13.86 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114857253 | CMS |
| Lilly USA, LLC | $14.71 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135434407 | CMS |
| Lilly USA, LLC | $15.38 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135351704 | CMS |
| Novo Nordisk Inc | $23.55 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096695467 | CMS |
| Novo Nordisk Inc | $17.74 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097441979 | CMS |
| Novo Nordisk Inc | $21.07 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097712295 | CMS |
| Novo Nordisk Inc | $24.70 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096584897 | CMS |
| Novo Nordisk Inc | $22.53 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097246358 | CMS |
| Novo Nordisk Inc | $14.49 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096844670 | CMS |
| PFIZER INC. | $20.84 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131629851 | CMS |
| Phathom Pharmaceuticals, Inc. | $13.26 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151116981 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.